top of page

Publications

Original Article

Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer

Cancer Diagnostics

2008

Authors:

Lu H, Goodell V, and Disis ML

Journal:

Journal of Proteome Research

Volume:

7(4)

Page:

1388-94

Review Article

Immune modulation as a therapeutic strategy for non-small-cell lung cancer

2008

Authors:

Holt GE and Disis ML

Journal:

Clinical Lung Cancer

Volume:

9(1)

Page:

S13-S19

Original Article

An analytical workflow for investigating cytokine profiles

Measuring Human Immunity

2008

Authors:

Siebert JC, Inokuma M, Waid DM, Pennock ND, Vaitaitis GM, Disis ML, Dunne JF, Wagner DH and Maecker HT

Journal:

Cytometry A

Volume:

73(4)

Page:

289-98

Review Article

Tumor stromal barriers to the success of adoptive T cell therapy

T Cell Function & Therapy

2008

Authors:

Phan V and Disis ML

Journal:

Cancer Immunology Immunotherapy

Volume:

57(2)

Page:

281-3

Methods

Precision and linearity targets for validation of an IFNγ ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides

Measuring Human Immunity

2008

Authors:

Maecker HT, Hassler J, Payne JK, Summers A, Comatas K, Ghanayem M, Morse MA, Clay TM, Lyerly HK, Bhatia S, Ghanekar SA, Maino VC, delaRosa C and Disis ML

Journal:

BMC Immunology

Volume:

9

Page:

9

Review Article

A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"

Measuring Human Immunity

2008

Authors:

Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Thurin M, Trinchieri G, Wang E, Wigginton J, Chaussabel D, Coukos G, Dhodapkar M, Hakansson L, Janetzki S, Kleen TO, Kirkwood JM, Maccalli C, Maecker H, Maio M, Malyguine A, Masucci G, Palucka AK, Potter DM, Ribas A, Rivoltini L, Schendel D, Seliger B, Selvan S, Slingluff CL Jr, Stroncek DF, StreicherH, Wu X, Zeskind B, Zhao Y, Zocca MB, Zwierzina H, Marincola FM.

Journal:

Journal of Translational Medicine

Volume:

6

Page:

81

Original Article

The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity

Tumor Microenvironment

2008

Authors:

Behrens MD, Wagner WM, Krco CJ, Erskine CL, Kalli KR, Krempski J, Gad EA, Disis ML and Knutson KL

Journal:

Blood

Volume:

111(3)

Page:

1472-9

Original Article

His-tag ELISA for the detection of humoral tumor-specific immunity

Cancer Diagnostics

2008

Authors:

Goodell V, McNeel D and Disis ML

Journal:

BMC Immunology

Volume:

9

Page:

23

Original Article

Insulin-like growth factor-binding protein-2 is a target for the immunomodulation of breast cancer

Cancer Vaccines

2008

Authors:

Park KH, Gad E, Goodell V, Dang Y, Wild T, Higgins D, Fintak P, Childs J, Dela Rosa C, Disis ML

Journal:

Cancer Research

Volume:

68(20)

Page:

8400-9

Review Article

Translational Research Working Group developmental pathway for immune response modifiers

2008

Authors:

Cheever MA, Schlom J, Weiner LM, Lyerly HK, Disis ML, Greenwood A, Grad O, Nelson WG; Translational Research Working Group.

Journal:

Clinical Cancer Research

Volume:

14(18)

Page:

5692-9

bottom of page